Immunosuppression Therapy in Kidney Transplantation

Area of Science:

• Nephrology
• Immunology
• Transplant Surgery

Background:

• Kidney transplantation is the primary treatment for end-stage kidney disease (ESKD).
• Advances in surgical techniques and immunotherapy have significantly improved transplant success rates.
• Graft survival rates are high at 95% (1 year) and 90% (5 years).

Purpose of the Study:

• To review the immunology of kidney transplantation.
• To focus on current immunosuppressive agents used in clinical practice.
• To discuss strategies for optimizing immunosuppression to enhance graft and patient survival while minimizing toxicity.

Main Methods:

• This is a review article.
• It synthesizes current knowledge on transplantation immunology.
• It analyzes the role and impact of various immunosuppressive agents.

Main Results:

• Despite advances, chronic rejection and medication complications remain significant challenges.
• Immunosuppressive agents are crucial for preventing acute rejection.
• The selection of immunosuppressive regimens impacts long-term allograft and patient survival.

Conclusions:

• Optimizing immunosuppressive therapy is key to improving long-term kidney transplant outcomes.
• Balancing efficacy and toxicity of immunosuppressants is essential for patient and graft survival.
• Further research into novel immunosuppressive strategies may overcome current limitations.